Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
Main Authors: | Yanglong Li, Megumi Narisawa, Zhe Huang, Xiangkunm Meng, Hailong Wang, Xueying Jin, Xionghu Shen, Xian Wu Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-11-01
|
Series: | The Journal of Clinical Hypertension |
Subjects: | |
Online Access: | https://doi.org/10.1111/jch.14378 |
Similar Items
-
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
by: Anthony Rodgers, et al.
Published: (2024-02-01) -
Effectiveness of indapamide/amlodipine single-pill combination in patients with isolated systolic hypertension: post-hoc analysis of the ARBALET study
by: Zh. D. Kobalava, et al.
Published: (2022-03-01) -
Clinical Efficacy and Tolerability of Antihypertensive Therapy with Single Pill Combinations of Telmisartan in Patients with Arterial Hypertension in Clinical Practice According to the ON TIME Observational Study
by: F. T. Ageev, et al.
Published: (2023-01-01) -
The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population‐based cross‐sectional study
by: Xiaoyang Luo, et al.
Published: (2024-09-01) -
Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG"
by: M. P. Savenkov, et al.
Published: (2021-09-01)